Joint Portfolio End-of-grant evaluation. Supporting the use of TRIPS Flexibilities

End-of-grant evaluation Medicines Patent Pool (MPPII)

Impact story: Medicines Patent Pool

Review of the Pibrentasvir patent landscape: A scoping report

Review of the Glecaprevir patent landscape: A scoping report

Unitaid’s approach to intellectual property

Thematic Narrative for Reproductive, Maternal, Newborn and Child Health (RMNCH)

Discussion Paper: Ensuring that essential medicines are also affordable medicines: challenges and options